Skip to main content
Retour
Watch Compare

Celularity Inc

Qualité des données : 100%
Également cotée sous CELUW NASDAQ
CELU
NASDAQ Manufacturing Chemicals
1,27 €
▼ 0,09 € (-6,62%)
Cap. Boursière: 38,93 M
Prix
1,35 €
Cap. Boursière
38,93 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -6,68 M
Capital efficient — spends only 0,31% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)138,11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-76,69%
Net Margin-198,75%
Op. Margin-119,60%

Sécurité

Debt / Equity
N/A
Current Ratio0,16
Interest CoverageN/A

Valorisation

PE (TTM)
-0,48
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % -198,8 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 2 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q22023 -0,30 € -2,70 € -800,0%
Q12023 -2,40 € -4,10 € -70,8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 138,11% Revenue Growth (3Y) 73,68%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 40,58 M Net Income (TTM) -80,65 M
ROE N/A ROA -68,78%
Gross Margin N/A Operating Margin -119,60%
Net Margin -198,75% Free Cash Flow (TTM) -6,68 M
ROIC -76,69% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,16
Interest Coverage N/A Asset Turnover 0,35
Working Capital -54,72 M Tangible Book Value -35,57 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,48 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17,17%
Market Cap 38,93 M Enterprise Value 38,81 M
Per Share
EPS (Diluted TTM) -3,33 Revenue / Share 1,41
FCF / Share -0,23 OCF / Share -0,23
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,31% FCF Conversion 8,29%
SBC-Adj. FCF -7,47 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 54,22 M 22,77 M 17,98 M 21,34 M —
Net Income -57,89 M -196,30 M 14,19 M -100,12 M -2,63 M
EPS (Diluted) -2,64 -11,02 0,09 — —
Gross Profit — 6,76 M -1,69 M 11,68 M —
Operating Income -38,36 M -192,29 M -25,60 M -109,06 M -4,22 M
EBITDA — — — — —
R&D Expenses 17,39 M 30,47 M 78,36 M 88,35 M —
SG&A Expenses 58,64 M 50,58 M 66,02 M 71,34 M —
D&A 7,92 M 9,32 M 9,44 M 8,82 M —
Interest Expense — — — — —
Income Tax 10 000,0 10 000,0 13 000,0 20 000,0 191 644,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 132,68 M 143,89 M 401,07 M 414,13 M 292,16 M
Total Liabilities 123,85 M 102,93 M 202,17 M 314,71 M 14,22 M
Shareholders' Equity 8,84 M 40,96 M 198,90 M 99,42 M 5,00 M
Total Debt — 17,22 M 37,60 M — —
Cash & Equivalents 738 000,0 227 000,0 13,97 M 37,24 M 314 696,0
Current Assets 20,56 M 19,79 M 33,50 M 59,10 M 359 289,0
Current Liabilities 53,68 M 67,30 M 62,09 M 26,23 M 3,41 M

Scores de Stratégies

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Value Price/Sales Ratio Focus (Ken Fisher)
#71 of 245
69

Activité Récente

Entré Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026